Pay in 4 interest-free payments of $7.15 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The UK MHRA has issued a specific safety warning that GLP-1 and dual GIP/GLP-1 medications are not substitutes for insulin
Transparent Pricing: Clear, upfront out-of-pocket costs with no hidden fees
These medications mimic the action of the hormone GLP-1 (glucagon-like peptide-1), which helps manage blood sugar levels by stimulating insulin release, reducing glucagon secretion, and slowing gastric emptying
Like many employers, they wanted to know: What is the real impact of GLP-1s on diabetes? Specifically, they want to understand whether the investment in GLP-1s has been effective in a) helping their diabetic population of nearly 3,000 employees and members better manage their chronic disease and b) addressing the $40M+ in annual spend for this population
US$ 29.02
US$ 25.12
US$ 25.64
US$ 28.76
